Myungmoon Phar (017180) - Net Assets

Latest as of December 2025: ₩104.46 Billion KRW ≈ $70.79 Million USD

Based on the latest financial reports, Myungmoon Phar (017180) has net assets worth ₩104.46 Billion KRW (≈ $70.79 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩272.46 Billion ≈ $184.64 Million USD) and total liabilities (₩168.00 Billion ≈ $113.85 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore 017180 asset base for the complete picture of this company's asset base.

Key Net Assets Metrics

Metric	Value
Current Net Assets	₩104.46 Billion
% of Total Assets	38.34%
Annual Growth Rate	3.13%
5-Year Change	21.64%
10-Year Change	10.33%
Growth Volatility	14.13

Myungmoon Phar - Net Assets Trend (2009–2025)

This chart illustrates how Myungmoon Phar's net assets have evolved over time, based on quarterly financial data. Check Myungmoon Phar (017180) tangible net worth to evaluate the tangible quality of the company's equity base.

Annual Net Assets for Myungmoon Phar (2009–2025)

The table below shows the annual net assets of Myungmoon Phar from 2009 to 2025. For live valuation and market cap data, see 017180 market cap.

Year	Net Assets	Change
2025-12-31	₩104.46 Billion ≈ $70.79 Million	+1.29%
2024-12-31	₩103.12 Billion ≈ $69.88 Million	+16.19%
2023-12-31	₩88.75 Billion ≈ $60.15 Million	-6.84%
2022-12-31	₩95.27 Billion ≈ $64.56 Million	+10.94%
2021-12-31	₩85.87 Billion ≈ $58.20 Million	-5.40%
2020-12-31	₩90.77 Billion ≈ $61.52 Million	+13.19%
2019-12-31	₩80.20 Billion ≈ $54.35 Million	-13.83%
2018-12-31	₩93.06 Billion ≈ $63.07 Million	-8.51%
2017-12-31	₩101.72 Billion ≈ $68.93 Million	+7.43%
2016-12-31	₩94.68 Billion ≈ $64.16 Million	+41.06%
2015-12-31	₩67.12 Billion ≈ $45.49 Million	-8.25%
2014-12-31	₩73.15 Billion ≈ $49.57 Million	-0.06%
2013-12-31	₩73.20 Billion ≈ $49.60 Million	+0.45%
2012-12-31	₩72.87 Billion ≈ $49.38 Million	-12.35%
2011-12-31	₩83.13 Billion ≈ $56.34 Million	+23.84%
2010-12-31	₩67.13 Billion ≈ $45.49 Million	+5.17%
2009-12-31	₩63.83 Billion ≈ $43.26 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Myungmoon Phar's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 333.3% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2025)

Component	Amount	Percentage
Retained Earnings	₩2.98 Billion	3.01%
Other Components	₩95.77 Billion	96.99%
Total Equity	₩98.74 Billion	100.00%

Myungmoon Phar Competitors by Market Cap

The table below lists competitors of Myungmoon Phar ranked by their market capitalization.

Company	Market Cap
Comelf SA RO:CMF	$24.67 Million
Kyobo 8 Special Purpose Acquisition Company KQ:307280	$24.68 Million
JPMorgan American Investment Trust LSE:JAM	$24.69 Million
Is Girisim Sermayesi Yatirim Ortakligi AS IS:ISGSY	$24.69 Million
Advancecon Holdings Bhd KLSE:5281	$24.65 Million
Korean Drug Co. Ltd KQ:014570	$24.65 Million
FIGENE CAPITAL SA ZY 1 F:20X	$24.64 Million
Choo Bee Metal Industries Bhd KLSE:5797	$24.62 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Myungmoon Phar's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 96,851,181,650 to 98,740,704,960, a change of 1,889,523,310 (2.0%).
Net income of 1,895,287,560 contributed positively to equity growth.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	₩1.90 Billion	+1.92%
Other Changes	₩-5.76 Million	-0.01%
Total Change	₩-	1.95%

Book Value vs Market Value Analysis

This analysis compares Myungmoon Phar's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 0.36x
The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2017-12-31	₩3901.38	₩1072.00	x
2018-12-31	₩3581.72	₩1072.00	x
2019-12-31	₩3055.72	₩1072.00	x
2020-12-31	₩2579.48	₩1072.00	x
2021-12-31	₩2374.06	₩1072.00	x
2022-12-31	₩2648.13	₩1072.00	x
2023-12-31	₩2488.74	₩1072.00	x
2024-12-31	₩2897.28	₩1072.00	x
2025-12-31	₩2953.80	₩1072.00	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Myungmoon Phar utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 1.92%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 0.97%
• Asset Turnover: 0.72x
• Equity Multiplier: 2.76x
Recent ROE (1.92%) is above the historical average (-3.46%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2009	5.02%	3.03%	0.63x	2.63x	₩-2.92 Billion
2010	5.00%	2.92%	0.64x	2.67x	₩-3.07 Billion
2011	5.86%	3.63%	0.62x	2.61x	₩-3.21 Billion
2013	1.50%	0.99%	0.54x	2.81x	₩-5.82 Billion
2014	1.10%	0.72%	0.55x	2.76x	₩-6.14 Billion
2015	-25.53%	-12.90%	0.63x	3.16x	₩-22.46 Billion
2016	7.41%	4.74%	0.64x	2.43x	₩-2.35 Billion
2017	7.99%	5.57%	0.60x	2.41x	₩-1.96 Billion
2018	1.10%	0.67%	0.61x	2.71x	₩-7.98 Billion
2019	-26.67%	-13.66%	0.56x	3.46x	₩-28.05 Billion
2020	-31.70%	-21.62%	0.53x	2.79x	₩-36.36 Billion
2021	-8.55%	-4.74%	0.65x	2.77x	₩-14.89 Billion
2022	8.79%	5.17%	0.66x	2.57x	₩-1.08 Billion
2023	-5.42%	-2.67%	0.72x	2.83x	₩-12.87 Billion
2024	-3.13%	-1.63%	0.72x	2.66x	₩-12.72 Billion
2025	1.92%	0.97%	0.72x	2.76x	₩-7.98 Billion

Industry Comparison

This section compares Myungmoon Phar's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

Industry: Drug Manufacturers - Specialty & Generic
Average net assets among peers: $481,699,596,243
Average return on equity (ROE) among peers: 1.66%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Myungmoon Phar (017180)	₩104.46 Billion	5.02%	1.61x	$24.67 Million
Dongwha Pharm.Co.Ltd (000020)	$378.67 Billion	5.38%	0.22x	$87.91 Million
Yuhan Corp. (000100)	$1.65 Trillion	3.48%	0.32x	$3.67 Billion
Yuhan Corp Preferred (000105)	$1.65 Trillion	2.42%	0.28x	$45.29 Million
Yuyu Pharma (000220)	$120.36 Billion	-5.97%	0.65x	$39.15 Million
Yuyu Pharma Inc (000225)	$128.69 Billion	-1.72%	0.50x	$14.81 Million
Yuyu Pharma Inc (000227)	$135.06 Billion	6.46%	0.54x	$29.39 Million
Ildong Holdings Co Ltd (000230)	$105.71 Billion	13.32%	1.07x	$46.37 Million
Samil Pharm (000520)	$65.75 Billion	-8.13%	2.44x	$89.20 Million
Donga Socio Holdings (000640)	$350.94 Billion	12.36%	1.19x	$384.83 Million
Jw Pharmac (001060)	$230.09 Billion	-10.98%	1.49x	$359.11 Million

About Myungmoon Phar

KO:017180 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$24.67 Million

₩36.40 Billion KRW

Market Cap Rank

#24366 Global

#1705 in Korea

Share Price

₩1072.00

Change (1 day)

+1.42%

52-Week Range

₩1057.00 - ₩1945.00

All Time High

₩10277.86